Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic PropertiesMatthew D. Hill, Andrew P. Degnan, Hong Huang et al.|ACS Medicinal Chemistry Letters|2022Cited by 10
Development of BET inhibitors as potential treatments for cancer: A new carboline chemotypeMatthew D. Hill, Andrew P. Degnan, Claude Quesnelle et al.|Bioorganic & Medicinal Chemistry Letters|2021Cited by 6